Viewing Study NCT00268918

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:03 AM
Ignite Modification Date: 2026-01-10 @ 4:20 AM
Study NCT ID: NCT00268918
Status: COMPLETED
Last Update Posted: 2018-07-27
First Post: 2005-12-21
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients
Sponsor: Dana-Farber Cancer Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Endometrial Cancer View
None Cervical Cancer View
None Fallopian Tube Cancer View
None Peritoneal Cancer View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PTK787 View
None Metastatic breast cancer View
None Refractory gynecological cancer View